73.22
2.94%
2.09
アフターアワーズ:
73.22
前日終値:
$71.13
開ける:
$73.11
24時間の取引高:
4.81M
Relative Volume:
1.00
時価総額:
$43.19B
収益:
$6.60B
当期純損益:
$4.16B
株価収益率:
10.57
EPS:
6.93
ネットキャッシュフロー:
$490.10M
1週間 パフォーマンス:
+6.22%
1か月 パフォーマンス:
-1.37%
6か月 パフォーマンス:
+15.05%
1年 パフォーマンス:
-0.92%
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
EW を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
73.22 | 43.19B | 6.60B | 4.16B | 490.10M | 6.93 |
ABT
Abbott Laboratories
|
128.81 | 223.42B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
103.04 | 151.86B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
390.43 | 148.84B | 22.60B | 2.99B | 3.49B | 7.76 |
MDT
Medtronic Plc
|
91.99 | 117.96B | 33.00B | 4.29B | 5.50B | 3.27 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
2024-07-25 | ダウングレード | Truist | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-03-29 | 開始されました | UBS | Neutral |
2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
2022-12-06 | ダウングレード | Stifel | Buy → Hold |
2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
2022-10-26 | 開始されました | Mizuho | Buy |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Buy |
2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
2022-04-13 | 開始されました | Truist | Buy |
2022-04-06 | 開始されました | Wolfe Research | Outperform |
2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
2022-03-02 | 再開されました | BofA Securities | Neutral |
2022-02-02 | アップグレード | UBS | Neutral → Buy |
2022-01-27 | 繰り返されました | Citigroup | Buy |
2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
2022-01-27 | 繰り返されました | Raymond James | Outperform |
2022-01-27 | 繰り返されました | Stifel | Buy |
2022-01-27 | 繰り返されました | UBS | Neutral |
2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
2021-07-30 | 繰り返されました | Jefferies | Buy |
2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
2021-07-30 | 繰り返されました | Stifel | Buy |
2021-07-30 | 繰り返されました | UBS | Neutral |
2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Neutral |
2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
2020-09-11 | 開始されました | Wolfe Research | Underperform |
2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Neutral |
2020-01-10 | 開始されました | Oppenheimer | Outperform |
2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
2019-09-23 | 開始されました | Piper Jaffray | Overweight |
2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
2019-01-03 | 開始されました | Deutsche Bank | Hold |
2018-11-28 | 開始されました | UBS | Neutral |
2018-10-16 | 開始されました | Barclays | Underweight |
2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
11 Analysts Have This To Say About Edwards Lifesciences - Benzinga
Edwards Lifesciences (NYSE:EW) Rating Increased to Buy at Stifel Nicolaus - MarketBeat
Swedbank AB Has $57.78 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Stifel Upgrades Edwards Lifesciences to Buy From Hold, Adjusts Price Target to $90 From $75 - Marketscreener.com
Stifel raises Edwards Lifesciences stock to buy, target to $90 - Investing.com
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MSN
KBC Group NV Sells 248,320 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Cuts Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO - Orange County Business Journal
Agree To Purchase Edwards Lifesciences At $55, Earn 7.8% Using Options - Nasdaq
Baldwin Wealth Partners LLC MA Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
United Asset Strategies Inc. Has $12.45 Million Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Stonehage Fleming Financial Services Holdings Ltd - MarketBeat
CX Institutional Buys New Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Harrell Investment Partners LLC Sells 12,378 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Smart Money Is Betting Big In Edwards Lifesciences Options - Benzinga
Manitou Investment Management Ltd. Increases Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Bought by Inspire Investing LLC - MarketBeat
What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing? - Yahoo Finance
Wendell David Associates Inc. Trims Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Nisa Investment Advisors LLC Grows Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by UMB Bank n.a. - MarketBeat
Edwards Lifesciences CVP Daniel Lippis sells $34,382 in stock - MSN
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
1,478,989 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Seilern Investment Management Ltd - MarketBeat
Gateway Investment Advisers LLC Acquires 5,726 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Sees Significant Growth in Short Interest - MarketBeat
Boston Common Asset Management LLC Lowers Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
65,442 Shares in Edwards Lifesciences Co. (NYSE:EW) Purchased by Avanza Fonder AB - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) VP Sells $34,380.00 in Stock - MarketBeat
Edwards Lifesciences CVP Daniel Lippis sells $34,382 in stock By Investing.com - Investing.com Canada
Wolfe Research Downgrades Edwards Lifesciences (EW) - MSN
Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)? - MSN
West Coast Financial LLC Has $9.87 Million Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Wolfe Research cuts Edwards Lifesciences stock rating to Underperform - MSN
Declining Stock and Solid Fundamentals: Is The Market Wrong About Edwards Lifesciences Corporation (NYSE:EW)? - Yahoo Finance
Wolfe Research Downgrades Edwards Lifesciences (NYSE:EW) to Underperform - MarketBeat
Should Edwards Lifesciences Stock Stay in Your Portfolio Now? - Yahoo Finance
Meril successful at EPO against Edwards Lifesciences in heart-valve battle - JUVE Patent
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Assenagon Asset Management S.A. Buys 3,506,886 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST Purchases 300,000 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences price target raised to $74 from $72 at Bernstein - MSN
Edwards Lifesciences’ Q4 2024 Earnings: What to Expect - Nasdaq
Edwards Lifesciences’ Q4 2024 Earnings: What To Expect - Barchart
Edwards Lifesciences Co. (NYSE:EW) Receives $79.40 Consensus Target Price from Analysts - MarketBeat
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Edwards Lifesciences Stock Price | EW Stock Quote, News, and History - Markets Insider
Brain Ischemia Market grow at CAGR of 7.6% Growth, Reaching $1,622 million by 2032 Globally - GlobeNewswire Inc.
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):